Back to search

National and Kapodistrian University of Athens

Φαρμακευτική νανοτεχνολογία: σχεδιασμός και ανάπτυξη νανοφορέων για γονιδιακή θεραπεία

Abstract

dc:description

The rapid advancements in the fields of molecular biology and genetic engineering have emerged gene therapy as an innovative and promising therapeutic approach, for the treatment of several genetic-based diseases and dysfunctions, even at the level of personalized medicine. Briefly, gene therapy is defined as the process by which a disease can be treated by modifying a patient’s cells and relies on the insertion of exogenous genetic sequences into mammalian cells, aiming to restore their normal function. The successful implementation of gene therapy treatment options requires the selection of the appropriate genetic material and the utilization of an efficient gene delivery system to deliver it to the desired target cells. The delivery systems currently used in gene therapy are divided into two main categories: viral vectors and non-viral vectors. Viral vectors (adenoviruses, retroviruses, herpesviruses, etc.) represent the first major category of gene delivery vectors and, due to their high therapeutic efficacy, are frequently encountered in the majority of clinical gene therapy trials. However, despite their high efficiency, the use of viral vectors for gene delivery poses certain limitations, particularly regarding their safety. The induction of immune responses and cytotoxicity, the risk of infection by pathogenic viruses, insertional mutagenesis, and potential oncogenic activity are some of these concerns. These limitations have led to the development of safer gene delivery methods, including non-viral delivery systems based on innovative nanomaterials. Over the last years, the evolution of Nanotechnology in the fields of medicine (Nanomedicine) and pharmaceutics (Pharmaceutical Nanotechnology) has contributed to the fabrication of innovative and multifunctional technological platforms at the nanoscale for a plethora of therapeutic applications. Among these, the contribution of nanotechnology to gene therapy applications is significant, with the development of effective non-viral nanocarriers for the delivery of various types of nucleic acids to the appropriate target cells. Furthermore, the multifunctionality of these nanocarriers facilitates the simultaneous co-administration of nucleic acids and other therapeutic compounds, providing the potential for combinational and targeted therapy. Non-viral gene therapy vectors include various types of nanostructures such as cationic polymers, cationic lipids, peptides and inorganic nanoparticles as gold nanoparticles, silica nanoparticles, quantum dots, carbon nanotubes, etc. In particular, nanostructures composed of cationic lipids and cationic polymers have been further investigated and examined in preclinical and clinical trials, demonstrating remarkable therapeutic results. Moreover, a novel approach which is expected to upgrade the functionality and enhance the therapeutic efficacy of non-viral nanocarriers is the combination of different types of materials. The combination among different materials, such as polymers and lipids, can modify their individual properties and generate hybrid nanostructures with new and improved features. In this regard, this PhD thesis focuses on the rational design and development of innovative nanotechnological platforms capable of delivering nucleic acids, with the prospect of their implementation as non-viral carriers for gene therapy applications. The developed nanotechnological platforms are mainly consisted of polymeric biomaterials, as well as copolymers combined with lipids to generate hybrid/chimeric multifunctional nanocarriers. Reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to synthesize novel copolymers, with different architectures and molecular characteristics. The synthesized copolymers include the poly(2-(dimethylamino) ethyl methacrylate)-b-poly(lauryl methacrylate) (PDMAEMA-b-PLMA) amphiphilic block copolymers, the poly[(2-(dimethylamino) ethyl methacrylate)-co-(oligo(ethylene glycol) methyl ether methacrylate] [P(DMAEMA-co-OEGMA)] double hydrophilic random copolymers and the poly[(stearyl methacrylate-co-oligo(ethylene glycol) methyl ether methacrylate] [P(SMA-co-OEGMA)] amphiphilic random copolymer. The copolymers consist of biocompatible, stimuli-responsive polymers according to the literature, polymers with functional cationic groups and polymers with stealth and shielding properties. The copolymers were molecularly characterized by means of size exclusion chromatography (SEC), proton nuclear magnetic resonance spectroscopy (1H-NMR) and attenuated total reflectance Fourier-transform infrared spectroscopy (ATR-FTIR). Furthermore, the copolymers comprised of the (P)DMAEMA block/segment were chemically modified via the quaternization of the tertiary amine group of (P)DMAEMA to quaternary ammonium salt. Hence, the copolymers were transformed to strong cationic polyelectrolytes with the quaternized Q(P)DMAEMA block/segment carrying a permanent positive charge, capable of exhibiting higher binding affinity to nucleic acids. The quaternized derivatives οf the precursor copolymers include the QPDMAEMA-b-PLMA amphiphilic cationic polyelectrolytes and the P(QDMAEMA-co-OEGMA) double hydrophilic random cationic polyelectrolytes. Overall, the implemented techniques revealed the successful synthesis and modification of the copolymers. Moreover, the determined molecular characteristics are in agreement with those of the experimental design. Following the synthesis and characterization procedures, the ability of the copolymers to self-assemble in aqueous media forming nanostructures like micelles or polymeric aggregates was examined. The physicochemical characteristics of the polymeric nanocarriers were determined by light scattering techniques, including dynamic (DLS), static (SLS) and electrophoretic (ELS). In particular, the size (hydrodynamic radius, (Rh)), size distribution and size polydispersity index (PDI) were determined by DLS, the radius of gyration (Rg) was determined by SLS in order to estimate the Rg/Rh ratio, which provides information on the morphology of the formed nanostructures, and the zeta-potential (ζp) was determined by ELS. Furthermore, the polymeric nanocarriers were assessed for their potential cytotoxicity effect on human normal cell line (HEK293) and breast cancer cell lines (4T1, MCF-7, MDA-MB-231, and T47D). The cell viability was evaluated by the MTS assay. Novel hybrid/chimeric nanosystems composed of lipids and copolymers were also developed as nanotechnological platforms for nucleic acid delivery. For their preparation, the synthesized via RAFT polymerization amphiphilic random copolymer P(SMA-co-OEGMA), the cationic 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP), and the non-ionic/zwitterionic L-α-phosphatidylcholine, hydrogenated soybean (soy) (HSPC) lipids, were utilized. The chimeric nanosystems were prepared by the thin film hydration method, in different lipid and copolymer molar ratio. Moreover, pure/conventional HSPC:DOTAP liposomes, in different lipid molar ratios, were also prepared using the same method for their comparison with the chimeric nanosystems regarding the effect of the copolymer on the characteristics of the formed nanostructures. The physicochemical characteristics of the chimeric and pure liposomal formulations were determined by light scattering techniques (DLS, SLS, ELS).The developed polymeric and chimeric/pure liposomal nanosystems were explored for their ability to electrostatically interact and form complexes with nucleic acids. Particularly, model double-stranded linear DNA molecules with different number of base pairs were utilized for these studies. The interaction ability of the nanosystems and the formed complexes with the DNA molecules were investigated using a gamut of instrumental analysis techniques, in order to comprehensively study their physicochemical and morphological characteristics. The implemented techniques include fluorescence spectroscopy (FS) (using the ethidium bromide quenching assay), Ultraviolet-Visible (UV-Vis) spectroscopy, light scattering techniques (DLS, SLS, ELS), and cryogenic transmission electron microscopy (Cryo-TEM). The techniques evinced the successful interaction of the nanosystems with the DNA molecules, and the formation of nanosized and colloidally stable complexes with well-defined physicochemical and morphological characteristics. Additionally, the effect of ionic strength on the stability and physicochemical characteristics of the complexes was examined by dynamic light scattering (DLS), as preliminary simulation of the physiological conditions of biological fluids. In most cases, the complexes exhibited colloidal stability under physiological ionic strength. In conclusion, different types of nanotechnological platforms were designed and developed, including polymeric (such as micelles, polymeric aggregates), liposomal and chimeric/hybrid nanosystems. The nanosystems were evaluated for their ability to interact with DNA, forming complexes. The components of each nanosystem were selected with the aim of improving their features and effectiveness for their implementation as non-viral vectors for nucleic acid delivery. The synergistic effect between different materials at the nanoscale can lead to the generation of multifunctional nanocarriers capable of effectively delivering effectively nucleic acids and other therapeutic compounds in one single platform, serving as advanced therapeutic tools for the development of advanced therapy medicinal products for gene therapy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chrysostomou, Varvara
  • Χρυσοστόμου, Βαρβάρα

Subjects

dc:subject × 31

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57771

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chrysostomou, Varvara; Χρυσοστόμου, Βαρβάρα. Φαρμακευτική νανοτεχνολογία: σχεδιασμός και ανάπτυξη νανοφορέων για γονιδιακή θεραπεία. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/57771